Thomas Di Raimondo Janux Therapeutics, Inc. (JANX) insider trading activity
Thomas Di Raimondo is Chief Scientific Officer of Janux Therapeutics, Inc.. Currently has a direct ownership of 97,938 shares of JANX, which is worth approximately $5.33 Million. The most recent transaction as insider was on Sep 27, 2024, when has been sold 5,000 shares (Common Stock) at a price of $46.72 per share, resulting in proceeds of $233,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
97.9K
n/a
3M change
n/a
12M change
Total Value Held
$5.33 Million
TD
Thomas Di Raimondo
Chief Scientific Officer
San Diego, CA